← All indications
Stress Disorders, Post-Traumatic
A class of traumatic stress disorders with symptoms that last more than one month.
Drugs by status
Approved for this indication (3)
Phase 4 trials (45)
- mifepristone
- oxytocin
- urea
- ketamine
- clonazepam
- cycloserine
- methylphenidate
- valproic acid
- duloxetine
- suvorexant
- escitalopram
- ziprasidone
- naltrexone
- haloperidol
- lorazepam
- levodopa
- topiramate
- fluoxetine
- dronabinol
- memantine
- mianserin
- pimavanserin
- magnesium sulfate
- prazosin
- propranolol
- risperidone
- 3,4-Methylenedioxymethamphetamine
- buprenorphine
- bupivacaine
- tetrahydrocannabinol
- +15 more
Phase 3 trials (23)
Phase 2 trials (63)
- nitrous oxide
- phenylephrine
- maltodextrin
- daridorexant
- 7-keto dehydroepiandrosterone
- acamprosate
- acetylcysteine
- bnc210
- nabilone
- atenolol
- d-serine
- dehydroepiandrosterone
- vofopitant
- perampanel
- galantamine
- ganaxolone
- sodium oxybate
- insulin human
- hydrocortisone
- ifenprodil
- iloperidone
- nitrogen
- carbidopa
- lithium
- lofexidine
- nalbuphine
- verucerfont
- nepicastat
- neuropeptide Y
- niacin
- +33 more
Phase 1 trials (19)
- mk-3168
- 18f-2-fluoro-2-deoxy-d-glucose fluorodeoxyglucose
- propofol
- abx-1431
- ayahuasca
- lipopolysaccharide
- guanfacine
- cobalamin
- lanicemine
- lidocaine
- typhoid vi polysaccharide vaccine
- sunflower oil
- estradiol
- allogeneic adipose derived mesenchymal stem cell
- curcumin
- perindopril
- aleozen
- lactobacillus reuteri
- fluoroethylnormemantine
Other trials (22)
Organizations
Organization Involved with Phase 4 Indications (64)
- INTRuST
- Takeda
- Forest Laboratories
- AstraZeneca
- Merck
- TEMPVA Research Group, Inc.
- Atlanta Research and Education Foundation
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Research Foundation for Mental Hygiene, Inc.
- National Institute of Mental Health (NIMH)
- National Institute of Neurological Disorders and Stroke (NINDS)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- United States Army
- University of Pennsylvania
- Augusta University
- Baylor University
- Brown University
- Cornell University
- Harvard University
- Emory University
- Georgetown University
- University of Washington
- Hoosier Cancer Research Network
- Howard University
- Indiana University
- Johns Hopkins University
- Mental Health Services in the Capital Region, Denmark
- New York University
- Northern California Institute of Research and Education
- Rhode Island Hospital
- +34 more
Organization Involved with Phase 3 Indications (29)
- Eli Lilly
- GlaxoSmithKline
- GW Pharmaceuticals Ltd.
- Otsuka
- Biomedical Research Foundation
- National Center for Research Resources (NCRR)
- National Institute of General Medical Sciences (NIGMS)
- Boston University
- Case Western Reserve University
- Chiba University
- Duke University
- McGill University
- Multidisciplinary Association for Psychedelic Studies
- University of Oklahoma
- University of Southern California
- University of Toyama
- Centre de recherche Fernand-Seguin, Hôpital Louis-H. Lafontaine
- Icahn School of Medicine at Mount Sinai
- Tonix Pharmaceuticals
- Allegheny Health Network
- MAPS Public Benefit Corporation
- Premier Research Group
- University of Montreal
- National Disaster Medical Center, Tachikawa, Tokyo ,Japan
- University of Paris
- Lundbeck
- National Intrepid Center of Excellence
- Government of Japan
- Nobilis Therapeutics Inc.
Organization Involved with Phase 2 Indications (46)
- Aptinyx
- Novartis
- American Society Of Thermalism And Climatology Inc
- Biotie Therapies
- Marinus Pharmaceuticals
- Synchroneuron Inc.
- Tilray
- Bionorica
- Bionomics Limited
- Columbia Northwest Pharmaceuticals
- National Institutes of Health (NIH)
- National Institute on Drug Abuse (NIDA)
- American Heart Association
- Beer Yaakov and Ness Ziona Mental Health Center
- Dartmouth University
- Herzog Hospital
- New York Medical College
- RTI International
- Seoul National University
- Tulane University
- University of South Carolina
- State University of New York
- Tel Aviv University
- University of British Columbia
- University of Toulouse
- US WorldMeds
- America Society of thermalism
- University of Victoria
- University of Lyon
- University of Texas at Houston
- +16 more
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (20)
- Ology Bioservices
- German Research Foundation
- Kent State University
- Kenya Medical Research Institute
- Makerere University
- Rainier Associates
- University of Heidelberg
- University of Maryland
- University of Saskatchewan
- University of Toronto
- University of Zurich
- University of Nairobi
- Pennsylvania State University
- Central Insitute of Mental Health, Dpt. of Psychosomatic and Psychotherapeutic Medicine
- Landstuhl Regional Medical Center
- Rowan University
- Lightfighter Trust
- Ohio Board of Regents
- Yeshiva University
- Northeast Ohio Medical University